Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
Published September 9, 2026 · Recall initiated: August 31, 2026
Summary
FDA records drug Class III recall D-0833-2026, published September 9, 2026 and initiated August 31, 2026. Recalling firm: Supernus Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 11304 bottles; Lot: Lot# 2145283, Exp Date: 31-Mar-2030. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications.
What to do
Voluntary: Firm initiated
Get an email if TROKENDI XR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TROKENDI XR
- Manufacturer
- Supernus Pharmaceuticals, Inc.
- Distributor
- US Nationwide.
- UPC
- 0317772101300
- Lot
- Lot# 2145283, Exp Date: 31-Mar-2030.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,September 9, 2026
- FDAtraZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva HrvatskaSeptember 9, 2026
- FDABroadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed OilSeptember 9, 2026
- FDATrokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: CatalentJuly 29, 2026
- FDATrokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: CatalentJune 2, 2021
- FDATrokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by:October 26, 2016
Questions about this recall
Was Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30. recalled?
Yes. FDA published recall D-0833-2026 on September 9, 2026. Reported hazard: Failed dissolution specifications.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TROKENDI XR. UPC: 0317772101300.